<DOC>
	<DOC>NCT00331578</DOC>
	<brief_summary>The trial aims to evaluate 12-month long-term efficiency of Excel stent in the treatment of coronary heart disease and inhibition of restenosis after coronary artery stenting as well as a 12 months' long-term safety after the cessation of clopidogrel as an anti-platelet drugs used for 6 months after the implantation of degradable drug coating stent.</brief_summary>
	<brief_title>Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent</brief_title>
	<detailed_description />
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>1. Patient who should be full fill the criteria of using Excel stent. 2. Each included patient should allowed to use Excel stent. 3. Complete revascularization can be achieved through one invasive operation. 1. Patient do not suitable to use Excel stent, for example, not tolerant to antiplatelet drug or undergo cardiac/noncardiac surgery recently. 2. Patient with multiple branch lesions, thus the single Excel stent cannot resolve the condition. 3. NYH Cardiac functional grading&gt;3 or Echocardiography LVEF&lt;0.3. 4. Patient with complete revascularization cannot be resolved by one operation.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>